Literature DB >> 16709175

Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.

L E Kemp1, B Mulloy, E Gherardi.   

Abstract

The receptor tyrosine kinase Met and its ligand HGF/SF (hepatocyte growth factor/scatter factor) are essential in the signalling pathways required for embryogenesis and tissue regeneration. Aberrant signalling of this complex is also a feature of many tumours and appears to contribute to the growth, invasiveness and metastasis of both carcinomas and sarcomas. HGF/SF, like many other angiogenic growth factors, employs heparan sulphate as co-receptor. The role of this interaction has not been completely defined but appears to be physiologically relevant. Thus the presence of heparin increases the potency of HGF/SF in experiments with cells in culture leading to elevated downstream signalling effects and, although not vital for the Met-HGF/SF interaction, heparin or heparan sulphate is essential for the activity of certain isoforms of HGF/SF, such as NK1 and NK2. Here, we summarize the progress made in understanding the interaction between heparin and heparan sulphate and NK1, NK2 and HGF/SF and we discuss their role in HGF/SF-Met signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709175     DOI: 10.1042/BST0340414

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  18 in total

1.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

Review 2.  Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis.

Authors:  Yeliz Yılmaz; Ayşim Güneş; Hande Topel; Neşe Atabey
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 3.  Immunoregulatory properties of the cytokine IL-34.

Authors:  Carole Guillonneau; Séverine Bézie; Ignacio Anegon
Journal:  Cell Mol Life Sci       Date:  2017-03-03       Impact factor: 9.261

4.  Tetraspanin CD81 is required for Listeria monocytogenes invasion.

Authors:  To Nam Tham; Edith Gouin; Eric Rubinstein; Claude Boucheix; Pascale Cossart; Javier Pizarro-Cerda
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

Review 5.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

6.  Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration.

Authors:  Su-Bo Wang; Yan-Na Cheng; Shu-Xiang Cui; Julia Li Zhong; S G Ward; Li-Rui Sun; Ming-Hui Chen; Norihiro Kokudo; Wei Tang; Xian-Jun Qu
Journal:  Clin Exp Metastasis       Date:  2009-03-05       Impact factor: 5.150

7.  Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes.

Authors:  Ke-Xin Liu; Yukio Kato; Kunio Matsumoto; Toshikazu Nakamura; Taiichi Kaku; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2009-01-06       Impact factor: 4.200

Review 8.  State of the structure address on MET receptor activation by HGF.

Authors:  Edmond M Linossi; Gabriella O Estevam; Masaya Oshima; James S Fraser; Eric A Collisson; Natalia Jura
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

9.  Cellularized biosynthetic microhydrogel polymers for intravascular liver tissue regeneration therapy.

Authors:  Tarek Saadi; Omri Nayshool; Julie Carmel; Arie Ariche; Zakhar Bramnik; Iris Mironi-Harpaz; Dror Seliktar; Yaacov Baruch
Journal:  Tissue Eng Part A       Date:  2014-08-19       Impact factor: 4.080

10.  A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.

Authors:  E Krajewska; C E Lewis; Y-Y Chen; A Welford; S Tazzyman; C A Staton
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.